On the possible increase in local tumour control probability for gliomas exhibiting low dose hyper-radiosensitivity using a pulsed schedule

British Journal of Radiology

Volumn 80, Issue 949, 2007, Pages 32-37

  Tomé, Wolfgang A ^a   Howard, S P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER CONTROL; CANCER RADIOTHERAPY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; LOW ENERGY RADIATION; PROBABILITY; RADIATION DOSE; RADIOSENSITIVITY; BIOLOGICAL MODEL; GLIOMA; RADIATION EXPOSURE; RADIATION RESPONSE; TUMOR CELL LINE;

CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, RADIATION; GLIOMA; HUMANS; MODELS, BIOLOGICAL; RADIATION TOLERANCE;

EID: 33947538511     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/15764945     Document Type: Article

References (32)

1. Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic astrocytoma: A cooperative clinical final. J Neurosurg 1978;49:333-43.
2. Walker MD, Green SB, Byar DP, E Alexander, U Batzdorf, WH Brooks, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-9.
3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 2005;352:987-96.
4. Bauman GS, Sneed PK, Wara WM, Stalpers LJ, Chang SM, McDermott MW, et al. Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 1996;36:433-41.
5. Salcman M, Scholtz H, Kaplan RS, Kulik S, Wilson CB, Black PM, et al. Long-term survival in patients with malignant astrocytoma. Neurosurgery 1994;34:213-20.
6. Hess KR, Wong ET, Jaeckle KA, Kyritsis AP, Levin VA, Prados MD, et al. Response and progression in recurrent malignant glioma Neuro-Oncol 1999;1:282-8.
7. McDermott MW, Sneed PK, Gutin PH. Interstitial brachytherapy for maligrant brain tumors. Semin Surg Oncol 1998;14:79-87.
8. Schultz CJ, Geard CR. Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation. Int J Radiat Oncol Biol Phys 1990;19:1397-403.
9. Schultz CJ, Davies BM. Confirmation of an inverse dose rate effect associated with a G2M block in two human glioblastoma cell lines. Proceedings of the 41st Annual Meeting of the Radiation Research Society; 1993 March 20-25; Dallas, Texas: 156.
10. Schultz CJ, Davies BM. G2M block characteristics as a function of dose rate in two human glioblastoma cell lines. Proceedings of the Radiation Research Society 42nd Annual Meeting; 1994 April 29-May 4; Nashville, TN: 177.
11. Pierquin B, Calitchi E, Mazeron J, Piedbois P, Julien M, Le Bourgeois JP. Comparison between low dose rate radiotherapy and conventionally fractionated irradiation in moderately extensive cancers of the oropharynx. Int J Radiat Oncol Biol Phys 1985;171:431-9.
12. Hamilton CS, Simpson SA, Ferguson S, Ostwald P, Hsu W, O'Brien M, et al. Low dose rate teletherapy and tumour response. Australas Radiol 1993;37:210-2.
13. Pierquin B, Calitchi E, Marinello G, et al. Comparaison entre irradiation fractioneé classique et irradiation é faible debit dans le traitement local des du sein évolués. Bulletin Du Cancer/ Radiotherapie 1991;78:125-32.
14. Cooper SG, Cardew AP, Ferguson S, Joseph DJ, Hamilton CS, Denham JW, et al. Low dose rate teletherapy using telecaesium 137 unit radiobiological, physical and clinical considerations. Australas Radiol 1990;34:241-6.
15. Wilson JF. Low dose rate teletherapy of unresectable carcinoma of the pancreas. Results of a pilot study. Proceedings of International Cancer Research workshop on low dose rate therapy. Am J Roentgenol 1978;131:1105-10.
16. Kuipers T. Clinical experience with low dose rate therapy at the Rotterdam Radiotherapy Institute. Proceedings of International Cancer Research Workshop on low dose rate therapy. Am J Roentgenol 1978;131:1105-10.
17. Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys 2001;49:379-89.
18. Marples B, Wouters BG, Collis SJ, Chalmers AJ, Joiner MC. Low-dose hyper-radiosensitivity: a consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiat Res 2004;161:247-55.
19. Short SC, Mitchell SA, Boulton P, Woodcock M, Joiner MC. The response of human glioma cell lines to low-dose radiation exposure. Int J Radiat Biol 1999;75:1341-8.
20. Short SC, Kelly J, Mayes CR, Woodcock M, Joiner MC. Low dose hypersensitivity after fractionated low-dose irradiation in vitro. Int J Radiat Biol 2001;77:655-64.
21. Tomé WA, Fowler JF. On the inclusion of the proliferation term into tumour control probability calculations for inhomogeneously irradiated tumours. Phys Med Biol 2003;48:N261-N268.
22. Tomé WA, Fenwick JD, Bentzen SM. Does a local bystander effect necessitate a revision of TCP models that are based on observed clinical data? Acta Oncol 2006;45: 406-11.
23. Marples B, Joiner MC Skov KA. The effect of oxygen on low dose hypersensitivity and increased radioresitance in Chinise hamster V79-379A cells. Radiat Res 1994;138(1 Suppl):S-17-20.
24. 2-phase cells and low-dose hyper-radiosensitivity: A pausible underlying mechanism? Radiat Res 2003;160:38-45.
25. Mu X, Loefroth P-O, Karlsson M, Zackrisson B. The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimization problem. Radiother Oncol 2003;68:181-7.
26. Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985;58:515-28.
27. Tomé WA, Welsh J, Fowler JF. The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimization problem: in regards to Mu et al, Radiother Oncol 2003;68:181-7.
28. Tomé WA, Welsh J, Fowler JF. The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimization problem: in regards to Mu et al, Radiother Oncol 2004;72:113-4.
29. Lea DE, Catcheside DG. The mechanism of induction by radiation of chromosome aberrations in tradescantia. J Genet 1942;44:216-54.
30. Marin L, Smith C, Langston M, Quashie D, Dillehay LE. Response of glioblastoma cell lines to low dose rate irradiation. Int J Radiat Oncol Biol Phys 1991;21:397-402.
31. Steel GG. Cellular sensitivity to low dose-rate irradiation focuses the problem of tumour radioresitance. Radiother Oncol 1991;20:63-72.
32. Gridley DS, Williams JR, Slater M. Low-dose/low-dose-rate radiation: a feasible strategy to improve cancer radiotherapy. Cancer Therapy 2005;3:105-30.